Dynamics in Post-pandemic Global HER2 Antibody Industry: Supply and Demand, Markets and Prices 2021-2027
Report Code: KNJ669150
Publisher: Date of Publish:
No. of Pages: 136 Category: Pharmaceuticals and Healthcare Publisher: Date of Publish:
Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global HER2 Antibody market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global HER2 Antibody market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027. Segmented by Category Trastuzumab Lapatinib Ado-trastuzumab Emtansine Pertuzumab Everolimus Segmented by End User/Segment Hospital Medical Center Segmented by Country North America United States Canada Mexico Europe Germany France UK Italy Russia Spain Asia Pacific China Japan Korea Southeast Asia India Australasia Central & South America Brazil Argentina Colombia Middle East & Africa Iran Israel Turkey South Africa Saudi Arabia Key manufacturers included in this survey Pfizer Novartis AG InvivoGen Genentech Inc Celltrion Bio-Techne Biocon Limited Abnova Corporation
Table of Contents 1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global HER2 Antibody Market Status and Forecast (2016-2027) 1.3.2 Global HER2 Antibody Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis 2 Global HER2 Antibody Supply by Company 2.1 Global HER2 Antibody Sales Volume by Company 2.2 Global HER2 Antibody Sales Value by Company 2.3 Global HER2 Antibody Price by Company 2.4 HER2 Antibody Production Location and Sales Area of Main Manufacturers 2.5 Trend of Concentration Rate 3 Global and Regional HER2 Antibody Market Status by Category 3.1 HER2 Antibody Category Introduction 3.1.1 Trastuzumab 3.1.2 Lapatinib 3.1.3 Ado-trastuzumab Emtansine 3.1.4 Pertuzumab 3.1.5 Everolimus 3.2 Global HER2 Antibody Market by Category 3.2.1 Global HER2 Antibody Sales Volume by Category (2016-2021) 3.2.2 Global HER2 Antibody Sales Value by Category (2016-2021) 3.2.3 Global HER2 Antibody Price by Category (2016-2021) 3.3 North America: by Category 3.4 Europe: by Category 3.5 Asia Pacific: by Category 3.6 Central & South America: by Category 3.7 Middle East & Africa: by Category 4 Global and Regional HER2 Antibody Market Status by End User/Segment 4.1 HER2 Antibody Segment by End User/Segment 4.1.1 Hospital 4.1.2 Medical Center 4.2 Global HER2 Antibody Market by End User/Segment 4.2.1 Global HER2 Antibody Sales Volume by End User/Segment (2016-2021) 4.2.2 Global HER2 Antibody Sales Value by End User/Segment (2016-2021) 4.2.3 Global HER2 Antibody Price by End User/Segment (2016-2021) 4.3 North America: by End User/Segment 4.4 Europe: by End User/Segment 4.5 Asia Pacific: by End User/Segment 4.6 Central & South America: by End User/Segment 4.7 Middle East & Africa: by End User/Segment 5 Global HER2 Antibody Market Status by Region 5.1 Global HER2 Antibody Market by Region 5.1.1 Global HER2 Antibody Sales Volume by Region 5.1.2 Global HER2 Antibody Sales Value by Region 5.2 North America HER2 Antibody Market Status 5.3 Europe HER2 Antibody Market Status 5.4 Asia Pacific HER2 Antibody Market Status 5.5 Central & South America HER2 Antibody Market Status 5.6 Middle East & Africa HER2 Antibody Market Status 6 North America HER2 Antibody Market Status 6.1 North America HER2 Antibody Market by Country 6.1.1 North America HER2 Antibody Sales Volume by Country (2016-2021) 6.1.2 North America HER2 Antibody Sales Value by Country (2016-2021) 6.2 United States 6.3 Canada 6.4 Mexico 7 Europe HER2 Antibody Market Status 7.1 Europe HER2 Antibody Market by Country 7.1.1 Europe HER2 Antibody Sales Volume by Country (2016-2021) 7.1.2 Europe HER2 Antibody Sales Value by Country (2016-2021) 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain 8 Asia Pacific HER2 Antibody Market Status 8.1 Asia Pacific HER2 Antibody Market by Country 8.1.1 Asia Pacific HER2 Antibody Sales Volume by Country (2016-2021) 8.1.2 Asia Pacific HER2 Antibody Sales Value by Country (2016-2021) 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia 9 Central & South America HER2 Antibody Market Status 9.1 Central & South America HER2 Antibody Market by Country 9.1.1 Central & South America HER2 Antibody Sales Volume by Country (2016-2021) 9.1.2 Central & South America HER2 Antibody Sales Value by Country (2016-2021) 9.2 Brazil 9.3 Argentina 9.4 Colombia 10 Middle East & Africa HER2 Antibody Market Status 10.1 Middle East & Africa HER2 Antibody Market by Country 10.1.1 Middle East & Africa HER2 Antibody Sales Volume by Country (2016-2021) 10.1.2 Middle East & Africa HER2 Antibody Sales Value by Country (2016-2021) 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia 11 Supply Chain and Manufacturing Cost Analysis 11.1 Supply Chain Analysis 11.2 Production Process Chart Analysis 11.3 Raw Materials and Key Suppliers Analysis 11.3.1 Raw Materials Introduction 11.3.2 Raw Materials Key Suppliers List 11.4 HER2 Antibody Manufacturing Cost Analysis 11.5 HER2 Antibody Sales Channel and Distributors Analysis 11.5.1 HER2 Antibody Sales Channel 11.5.2 HER2 Antibody Distributors 11.6 HER2 Antibody Downstream Major Buyers 12 Global HER2 Antibody Market Forecast by Category and by End User/Segment 12.1 Global HER2 Antibody Sales Volume and Sales Value Forecast (2022-2027) 12.2 Global HER2 Antibody Forecast by Category 12.2.1 Global HER2 Antibody Sales Volume Forecast by Category 12.2.2 Global HER2 Antibody Sales Value Forecast by Category 12.2.3 Global HER2 Antibody Price Forecast by Category 12.3 Global HER2 Antibody Forecast by End User/Segment 12.3.1 Global HER2 Antibody Sales Volume Forecast by End User/Segment 12.3.2 Global HER2 Antibody Sales Value Forecast by End User/Segment 12.3.3 Global HER2 Antibody Price Forecast by End User/Segment 13 Global HER2 Antibody Market Forecast by Region/Country 13.1 Global HER2 Antibody Market Forecast by Region (2022-2027) 13.1.1 Global HER2 Antibody Sales Volume Forecast by Region (2022-2027) 13.1.2 Global HER2 Antibody Sales Value Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast 14 Key Participants Company Information 14.1 Pfizer 14.1.1 Company Information 14.1.2 HER2 Antibody Product Introduction 14.1.3 Pfizer HER2 Antibody Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.1.4 SWOT Analysis 14.2 Novartis AG 14.2.1 Company Information 14.2.2 HER2 Antibody Product Introduction 14.2.3 Novartis AG HER2 Antibody Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.2.4 SWOT Analysis 14.3 InvivoGen 14.3.1 Company Information 14.3.2 HER2 Antibody Product Introduction 14.3.3 InvivoGen HER2 Antibody Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.3.4 SWOT Analysis 14.4 Genentech Inc 14.4.1 Company Information 14.4.2 HER2 Antibody Product Introduction 14.4.3 Genentech Inc HER2 Antibody Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.4.4 SWOT Analysis 14.5 Celltrion 14.5.1 Company Information 14.5.2 HER2 Antibody Product Introduction 14.5.3 Celltrion HER2 Antibody Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.5.4 SWOT Analysis 14.6 Bio-Techne 14.6.1 Company Information 14.6.2 HER2 Antibody Product Introduction 14.6.3 Bio-Techne HER2 Antibody Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.6.4 SWOT Analysis 14.7 Biocon Limited 14.7.1 Company Information 14.7.2 HER2 Antibody Product Introduction 14.7.3 Biocon Limited HER2 Antibody Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.7.4 SWOT Analysis 14.8 Abnova Corporation 14.8.1 Company Information 14.8.2 HER2 Antibody Product Introduction 14.8.3 Abnova Corporation HER2 Antibody Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.8.4 SWOT Analysis 15 Conclusion 16 Methodology
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com